Ho Peter Tai-Ching

Avg. Two Year Performance

(28%) Avg. Purchase Return
(13%) Compound
21% Avg. Sale Return
10% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return4%(< 1%)(21%)(37%)(28%)
Purchase Success Rate2 of 42 of 40 of 40 of 40 of 4
Average Sale Return5%2%< 1%19%21%
Sale Success Rate4 of 74 of 73 of 75 of 76 of 7
Drugs » Biotechnology

Chief Development Officer:

Holdings: 32.25K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Drugs - Generic

Director:

Holdings: 55.35K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--